Phoslo: all about pills

Phoslo is a mineral. It is used to treat kindny failure in late stage. It works reducing phosphate leves.

Clinico-pharmacological group

Drug for the treatment of hyperphosphatemia

Phoslo is a mineral. It is used to treat kindny failure in late stage. It works reducing phosphate leves. Package. Price. Per Pills.

Phoslo is a mineral. It is used to treat kindny failure in late stage. It works reducing phosphate leves. Package. Price. Per Pills.

Release form, composition and packing

Tablets, film-coated, white to pale yellow, oblong, scored on one side; at fault: the core tablet of white or nearly white.

1 tab.

435 mg calcium acetate

235 mg magnesium hydroxycarbonate

Excipients: pregelatinized starch, corn starch, sucrose, gelatin, croscarmellose sodium, magnesium stearate.

Cover structure: a castor bean seed oil, Valium.

180 pcs. – Banks of high strength polyethylene.

Indications

Treatment of hyperphosphatemia associated with chronic renal insufficiency in patients undergoing dialysis (hemodialysis, peritoneal dialysis).

Contraindications

– Hypophosphatemia;

– Clinical symptoms of hypercalcemia with or without, for example, as a result of an overdose of vitamin D, paraneoplastic syndrome (bronchial carcinoma, breast cancer, renal cell carcinoma, plasmacytoma), bone metastases, sarcoidosis or immobilization osteoporosis;

– Increased serum levels of magnesium, more than 2 mmol / l, and / or symptoms gipermagniemii;

– Degree atrioventricular block III;

– Myasthenia gravis;

– Hypersensitivity to the active substance or to any of the excipients;

– Children’s age (18 years).

Side effects

Determining the frequency of adverse reactions: very often – ≥1 / 10, often – from ≥1 / 100 to <1/10, sometimes – by ≥1 / 1,000 to <1/100, rare – of ≥1 / 10,000 to 2.6 mmol / L) may occur in approximately 1% of patients and may be asymptomatic or manifested by symptoms such as constipation, anorexia, nausea and vomiting; sometimes – hypercalcemia, moderate to severe, accompanied by symptoms; gipermagniemiya accompanied by symptoms. Hypercalcemia greater extent (Ca> 3.0 mmol / L) may occur in approximately 0.1% of patients and may be associated with cardiac arrhythmia, confusion, lethargy, delirium, stupor and in very severe cases – coma.

Carefully

– Refractory to therapy,

– Refractory hyperkalemia,

– Clinically relevant bradycardia or atrioventricular block second degree with bradycardia.